PPAR alpha activation protects against cholestatic liver injury
Zhao, Qi1,2; Yang, Rui1,2; Wang, Jing1; Hu, Dan-Dan1,3,4; Li, Fei1
2017-08-30
发表期刊SCIENTIFIC REPORTS
ISSN2045-2322
卷号7页码:9967
摘要Intrahepatic cholestasis induced by drug toxicity, bile salt export pump (BSEP) deficiency, or pregnancy frequently causes cholestatic liver damage, which ultimately may lead to liver fibrosis and cirrhosis. Here, the preventive and therapeutic effects of peroxisome proliferator-activated receptor alpha (PPAR alpha) signaling activated by fenofibrate was evaluated on cholestatic liver damage. Metabolomic analysis revealed that alpha-naphthyl isothiocyanate (ANIT)-induced intrahepatic cholestasis resulted in the accumulation of serum long-chain acylcarnitines and triglyceride, and the reduced expression of four fatty acid beta-oxidation (beta-FAO) relevant genes (Cpt1b, Cpt2, Mcad and Hadha), indicating the disruption of beta-FAO. The increase of acylcarnitines in hepatic cell resulted in the enhanced expression of anti-oxidative genes glutathione S-transferases (Gsta2 and Gstm3) directly. As direct PPAR alpha-regulated genes, Cpt1b, Cpt2, and Mcad were up-regulated after pretreatment with PPAR alpha agonist, fenofibrate, indicating the improvement of beta-FAO. In the end, the disrupted bile acid metabolism in the enterohepatic circulation and the enhanced oxidative stress and inflammation cytokines induced by ANIT exposure were significantly recovered with the improvement of beta-FAO using fenofibrate treatment. These findings provide the rationale for the use of PPAR alpha agonists as therapeutic alternatives for cholestatic liver damage.
关键词Primary Biliary-cirrhosis Bile-acid Homeostasis Receptor-alpha Ursodeoxycholic Acid Cholesterol 7-alpha-hydroxylase Beta-oxidation Fenofibrate Therapy Mice Hepatotoxicity
收录类别SCI
语种英语
引用统计
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/54911
专题中国科学院东亚植物多样性与生物地理学重点实验室
作者单位1.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China
2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
3.Kunming Med Univ, Sch Pharmaceut Sci, Kunming 650500, Yunnan, Peoples R China
4.Kunming Med Univ, Yunnan Key Lab Pharmacol Nat Prod, Kunming 650500, Yunnan, Peoples R China
推荐引用方式
GB/T 7714
Zhao, Qi,Yang, Rui,Wang, Jing,et al. PPAR alpha activation protects against cholestatic liver injury[J]. SCIENTIFIC REPORTS,2017,7:9967.
APA Zhao, Qi,Yang, Rui,Wang, Jing,Hu, Dan-Dan,&Li, Fei.(2017).PPAR alpha activation protects against cholestatic liver injury.SCIENTIFIC REPORTS,7,9967.
MLA Zhao, Qi,et al."PPAR alpha activation protects against cholestatic liver injury".SCIENTIFIC REPORTS 7(2017):9967.
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
s41598-017-10524-6.p(7693KB)期刊论文作者接受稿开放获取CC BY-NC-SA浏览 下载
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhao, Qi]的文章
[Yang, Rui]的文章
[Wang, Jing]的文章
百度学术
百度学术中相似的文章
[Zhao, Qi]的文章
[Yang, Rui]的文章
[Wang, Jing]的文章
必应学术
必应学术中相似的文章
[Zhao, Qi]的文章
[Yang, Rui]的文章
[Wang, Jing]的文章
相关权益政策
暂无数据
收藏/分享
文件名: s41598-017-10524-6.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。